STOCK TITAN

Elanco Animal Health Incorporated - ELAN STOCK NEWS

Welcome to our dedicated page for Elanco Animal Health Incorporated news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health Incorporated stock.

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health, committed to innovating and delivering products and services to improve the health and wellness of both farm animals and pets. Established with nearly 70 years of heritage, Elanco operates in over 90 countries with a diverse portfolio of approximately 200 brands. Their core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue through three primary avenues:

  • Enhancing food security by improving the health and productivity of farm animals, thereby contributing to a safer, more affordable, and abundant food supply.
  • Helping pets live longer, healthier lives through advanced veterinary products.
  • Improving food safety standards globally.

Elanco’s dedication to animal health is reflected in their continuous innovation and quality systems, driven by a shared vision of enhancing life for animals and humans alike. This commitment is evident in their recent achievements and ongoing projects. For instance, Elanco's collaboration with Agtech company, Cattler, aims to provide data-driven solutions to cattle farmers, enhancing operational efficiency and productivity through services like Benchmark™ and Experior™.

Elanco's financial health is strong, with the company reporting consistent revenue growth and strategic investments aimed at future expansion. In their recent financial results, Elanco posted a 5% growth in the fourth quarter and strengthened their commercial infrastructure to support ongoing and future growth. They also announced the divestiture of their aqua business to streamline operations and focus on core areas, which is expected to reduce their debt leverage significantly by year-end.

Environmental sustainability is another critical focus for Elanco. Their recent partnership with Athian to create a livestock carbon insetting marketplace is a significant step towards reducing greenhouse gas emissions in the dairy and beef industries. Products like Bovaer®, which significantly reduce methane emissions from cattle, exemplify Elanco's commitment to sustainable farming practices.

Overall, Elanco continues to be at the forefront of animal health innovation, with substantial investments in R&D, strategic partnerships, and a clear commitment to sustainability and community health.

Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) will participate in the BofA Securities 2022 Virtual Animal Health Summit on February 24, 2022. Jeff Simmons, president and CEO, is scheduled for a virtual fireside chat at 1:35 p.m. ET. A live audio webcast will be accessible in the "Events and Presentations" section of Elanco’s investor website, with a replay available for 30 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
conferences
-
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) will release its Q4 and full year 2021 financial results on February 24, 2022. A conference call detailing the company’s performance is scheduled for 8:00 a.m. ET that day, accessible via a live webcast on Elanco’s website. The company has a long-standing commitment to enhancing animal health and sustainability through innovative products and services, leveraging nearly 70 years of expertise in the industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.8%
Tags
-
Rhea-AI Summary

The FDA has approved Zorbium, a new transdermal solution for managing postoperative pain in cats, marking a significant expansion of Elanco's pain management portfolio. This long-acting medication offers up to four days of postoperative pain control from a single dose, reducing the burden on pet owners for at-home medication administration. Anticipated to launch mid-year 2022, Zorbium underscores Elanco's commitment to innovation in veterinary pain relief, addressing an unmet market need.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. CEO Jeff Simmons is set to present at 10:30 a.m. ET, addressing questions from analysts. A live audio webcast of the event will be accessible on Elanco's investor website, with a replay available for 30 days afterward. Elanco is dedicated to improving animal health with nearly 70 years of experience, focusing on creating value for farmers and pet owners through innovative products and services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
conferences
-
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) announced a significant restructuring plan aimed at simplifying its organization, including eliminating approximately 380 positions, or 20% of senior management, which will incur a fourth quarter charge of $65-$71 million. The company expects this restructuring to generate around $70 million in annual savings, directing resources into high-growth areas, especially in digital capabilities and the Chinese market. Despite the restructuring costs, Elanco maintains its goal of achieving a 60% adjusted gross margin by 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
none
-
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) will participate in the Evercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021. Jeff Simmons, CEO, will join a virtual fireside chat at 1:50 p.m. ET. A live audio webcast will be available on Elanco’s investor website, with a replay available for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
conferences
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) has joined the Greener Cattle Initiative, committing approximately $5 million over five years to fund research aimed at reducing methane emissions in beef and dairy production. This effort, led by the Foundation for Food & Agriculture Research, responds to the urgent need for climate action as highlighted by the UN. Elanco's participation aligns with its sustainability goals, including its pledge to remove 21 million tons of emissions from customer farms by 2030.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
none
-
Rhea-AI Summary

Elanco Animal Health reported a 27% increase in third quarter revenue, reaching $1,131 million, boosted by the Bayer Animal Health acquisition. The company updated its full-year revenue guidance to $4,730 to $4,770 million while maintaining adjusted EPS guidance of $0.97 to $1.03. However, reported EPS was $(0.21). Gross margin improved significantly to 55.6%. Elanco's operational performance reflected strong fundamentals, particularly in the Farm Animal and Pet Health sectors, with significant product contributions. The company anticipates continued growth in 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.71%
Tags
none
-
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) has been recognized in FORTUNE’s 2021 Change the World list, ranking 19th among 53 companies making a social or environmental impact. This accolade highlights Elanco's East Africa Growth Accelerator (EAGA), which supports smallholder farmers in Tanzania, Kenya, and Uganda by providing affordable veterinary products and training. The initiative, begun in 2017 with backing from the Bill & Melinda Gates Foundation, integrates into Elanco's operations, emphasizing animal health's role in addressing hunger and climate challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
none
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) is set to announce its third quarter 2021 financial results on November 5, 2021. A conference call will follow at 8:00 a.m. eastern time to discuss the company's performance, accessible via a live webcast on Elanco's website. The company specializes in products and services aimed at preventing and treating diseases in farm animals and pets, emphasizing sustainability and community impact. With nearly 70 years of experience in animal health, Elanco aims to improve the welfare of animals globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags

FAQ

What is the current stock price of Elanco Animal Health Incorporated (ELAN)?

The current stock price of Elanco Animal Health Incorporated (ELAN) is $13.98 as of November 15, 2024.

What is the market cap of Elanco Animal Health Incorporated (ELAN)?

The market cap of Elanco Animal Health Incorporated (ELAN) is approximately 6.8B.

What is Elanco Animal Health's core mission?

Elanco's core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue by enhancing food security, improving pet health, and elevating food safety standards globally.

In how many countries does Elanco operate?

Elanco operates in over 90 countries worldwide.

What recent collaborations has Elanco engaged in?

Elanco recently collaborated with Agtech company Cattler to provide data-driven solutions to cattle farmers through services like Benchmark™ and Experior™.

What is the significance of Elanco's partnership with Athian?

The partnership with Athian aims to create a livestock carbon insetting marketplace, reducing greenhouse gas emissions and promoting sustainable farming practices.

What are some of Elanco's notable products?

Elanco's notable products include Seresto®, Experior™, and Bovaer®, the latter being a methane-reducing feed ingredient for cattle.

How is Elanco addressing sustainability in animal farming?

Elanco addresses sustainability through innovative products like Bovaer®, which reduces methane emissions from cattle, and partnerships aimed at creating carbon insetting marketplaces.

What financial goals has Elanco set for 2024?

Elanco expects constant currency revenue growth of 2% to 3% for 2024, driven by new product launches and operational improvements. They also anticipate significant debt reduction through strategic divestitures.

How does Elanco contribute to food safety?

Elanco contributes to food safety by developing products that improve the health and performance of farm animals, thereby ensuring a safer and more reliable food supply.

What is Elanco's approach to innovation?

Elanco's approach to innovation involves continuous R&D investments, strategic partnerships, and the development of new products that address pressing issues in animal health and sustainability.

How does Elanco support the health and wellness of pets?

Elanco supports pet health through an extensive range of veterinary products designed to improve the quality and longevity of pets' lives.

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Stock Data

6.81B
494.35M
0.66%
100.35%
2.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD